Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ0,00
KB0,00
PKN52,8252,90,38
Msft0,11
Nokia4,40054,531,35
IBM1,25
Mercedes-Benz Group AG55,8655,88-0,76
PFE1,65
24.01.2025 0:38:57
Indexy online
AD Index online
select
AD Index online
 

  • 23.01.2025
Cochlear Ltd (COH.F, Frankfurt)
Závěr k 23.1.2025 Změna (%) Změna (EUR) Objem obchodů (EUR)
188,96 -0,07 -0,14 9 826
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace: 24.01.2025
Popis společnosti
Obecné informace
Název společnostiCochlear Ltd
TickerCOH
Kmenové akcie:Fully Paid Ord. Shrs
RICCOH.AX
ISINAU000000COH5
Poslední známé roční výsledky30.06.2024
Poslední známé čtvrtletní výsledky30.06.2024
Počet zaměstnanců k 30.06.2024 5 000
Akcie v oběhu k 30.06.2024 65 494 161
MěnaAUD
Kontaktní informace
Ulice1 University Avenue
MěstoSYDNEY
PSČ2109
ZeměAustralia
Kontatní osoba 
Funkce kontaktní osoby 
Telefon61 294 286 555
Fax61294286352

Business Summary: Cochlear Limited is an Australia-based company, which provides implantable hearing solutions and sound processors. The Company is engaged in development, manufacture and commercialization of implantable hearing solutions. Its segments include Cochlear implants, Services (sound processor upgrades and other) and Acoustics. The Company’s products and services portfolio include Cochlear implant portfolio, Acoustic solutions portfolio, and Recipient support tools. Its Cochlear Connected Care solutions include Cochlear Nucleus SmartNav System, Cochlear Custom Sound Pro Fitting Software, Cochlear Link, Cochlear Remote Assist, and Cochlear Remote Check solution for cochlear implants. Its Cochlear implant portfolio include Cochlear Nucleus System. Its Acoustic solutions portfolio include Cochlear Osia System, and Cochlear Baha System. Its Recipient support tools include Cochlear Nucleus, Baha and Osia Smart Apps and Cochlear CoPilot App.
Financial Summary: BRIEF: For the fiscal year ended 30 June 2024, Cochlear Ltd revenues increased 15% to A$2.24B. Net income increased 19% to A$356.8M. Revenues reflect Americas segment increase of 17% to A$1.14B, EMEA segment increase of 17% to A$745.6M, Americas segment increase of 17% to A$1.14B, EMEA segment increase of 17% to A$745.6M. Net income benefited from Net foreign exchange loss decrease of 53% to A$4.8M (expense).
Odvětvová klasifikace
TRBC2009Advanced Medical Equipment
TRBC2012Medical Prosthetics
RBSS2004Advanced Medical Equipment
MGINDUSTRYMedical Equipment & Supplies
MGSECTORHealthcare
NAICSElectromedical and Electrotherapeutic Apparatus Manufacturing
NAICS2007Electromedical Apparatus Mfg
NAICS1997Electromedical and Electrotherapeutic Apparatus Manufacturing
SICElectromedical Equipment



  • Poslední aktualizace: 24.01.2025
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
President, Chief Executive Officer, Executive DirectorDiggory Howitt5603.01.2018
Chief Financial OfficerStuart Sayers-12.02.2021
Chief Financial OfficerSarah Thom-01.01.202501.01.2025
President - North AmericaLisa Aubert-01.04.202201.04.2022
President - Asia Pacific Region & Latin American RegionsAnthony Bishop-28.07.2016
President - EMEA and Latin American RegionRichard Brook-
Senior Vice President - Global Strategic MarketingDean Phizacklea-28.07.201628.07.2016
Senior Vice President - Supply Chain & Operational ExcellenceGreg Bodkin-
Senior Vice President - People and CultureJennifer Hornery-01.01.2017
Senior Vice President - Clinical Strategy and InnovationBrian Kaplan-01.01.2019